SPINK2 and testicular cancer: On downregulation of SPINK2 in testicular cancer tissues, the combined effect of SPINK2 and RARRES1 significantly inhibits testicular cancer cell EMT by downregulating the uPA/uPA receptor signaling pathway [13].